KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Work In Process (2018 - 2022)

TherapeuticsMD's Work In Process history spans 5 years, with the latest figure at $218000.0 for Q3 2022.

  • For Q3 2022, Work In Process fell 68.31% year-over-year to $218000.0; the TTM value through Sep 2022 reached $218000.0, down 68.31%, while the annual FY2021 figure was $1.6 million, 83.46% up from the prior year.
  • Work In Process reached $218000.0 in Q3 2022 per TXMD's latest filing, down from $1.7 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $1.7 million in Q2 2022 to a low of $83911.0 in Q3 2018.
  • Average Work In Process over 5 years is $849310.4, with a median of $808694.0 recorded in 2019.
  • Peak YoY movement for Work In Process: surged 1098.38% in 2019, then plummeted 68.31% in 2022.
  • A 5-year view of Work In Process shows it stood at $339312.0 in 2018, then soared by 248.37% to $1.2 million in 2019, then dropped by 24.28% to $895000.0 in 2020, then soared by 83.46% to $1.6 million in 2021, then tumbled by 86.72% to $218000.0 in 2022.
  • Per Business Quant, the three most recent readings for TXMD's Work In Process are $218000.0 (Q3 2022), $1.7 million (Q2 2022), and $1.2 million (Q1 2022).